Saoussen Oueslati

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications

Wildlife as a reservoir of OXA-48-like carbapenemase-producing Enterobacterales.

Wildlife as a reservoir of OXA-48-like carbapenemase-producing Enterobacterales.

Journal: Microbiology spectrum
Published: July 21, 2026

Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like.

Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like.

Journal: Antimicrobial agents and chemotherapy
Published: June 30, 2026

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".

Journal: Antimicrobial agents and chemotherapy
Published: June 24, 2026

Chalcone-Terpene Hybrids from Fissistigma litseifolium (King) Merr as Potential Carbapenemase Inhibitors.

Chalcone-Terpene Hybrids from Fissistigma litseifolium (King) Merr as Potential Carbapenemase Inhibitors.

Journal: Journal of natural products
Published: May 30, 2026

Evaluation of the NG-TEST® blood culture PREP kit for ESBL directly from positive blood cultures using the NG-TEST® CTX-M MULTI lateral flow immunoassay.

Evaluation of the NG-TEST® blood culture PREP kit for ESBL directly from positive blood cultures using the NG-TEST® CTX-M MULTI lateral flow immunoassay.

Journal: JAC-antimicrobial resistance
Published: May 21, 2026

Improved hydrolysis of piperacillin by OXA-48-like R214G variants, a selective advantage under piperacillin-tazobactam exposure.

Improved hydrolysis of piperacillin by OXA-48-like R214G variants, a selective advantage under piperacillin-tazobactam exposure.

Journal: Antimicrobial agents and chemotherapy
Published: April 29, 2026

Evaluation of a Novel In Vitro Diagnostic Immunoassay for the Rapid Qualitative Detection of KPC, NDM, OXA-48-like, IMP and VIM Carbapenemases.

Evaluation of a Novel In Vitro Diagnostic Immunoassay for the Rapid Qualitative Detection of KPC, NDM, OXA-48-like, IMP and VIM Carbapenemases.

Journal: Diagnostics (Basel, Switzerland)
Published: April 27, 2026

Convergent S318T substitution in ADC enzymes contributes to reduced meropenem susceptibility in epidemic IC2 Acinetobacter baumannii.

Convergent S318T substitution in ADC enzymes contributes to reduced meropenem susceptibility in epidemic IC2 Acinetobacter baumannii.

Journal: Journal of global antimicrobial resistance
Published: March 11, 2026

Genomic characterization of a Klebsiella pneumoniae ST231 clinical isolate from Tunisia co-producing mcr-1.1 and blaOXA-181.

Genomic characterization of a Klebsiella pneumoniae ST231 clinical isolate from Tunisia co-producing mcr-1.1 and blaOXA-181.

Journal: Journal of global antimicrobial resistance
Published: March 06, 2026

In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.

In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.

Journal: Antimicrobial agents and chemotherapy
Published: February 12, 2026

Enterobacter roggenkampii ST422 with highly conjugative IncP plasmid carrying bla KPC-2 gene from Lebanon: a case report.

Enterobacter roggenkampii ST422 with highly conjugative IncP plasmid carrying bla KPC-2 gene from Lebanon: a case report.

Journal: ASM case reports
Published: January 06, 2026

Carbapenem and colistin-resistant Klebsiella pneumoniae co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia.

Carbapenem and colistin-resistant Klebsiella pneumoniae co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia.

Journal: JAC-antimicrobial resistance
Published: December 16, 2025
Showing 1-12 of 85

Last Updated: 09/26/2026